SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for GSK (GSK) — Nov 30, 2011

GSK plc
Date: Nov. 30, 2011 · CIK: 0001131399 · Accession: 0000000000-11-068914

AI Filing Summary & Sentiment

File numbers found in text: 001-15170

Date
November 30, 2011
Author
Not clearly detected
Form
UPLOAD
Company
GSK plc

Letter

November 30, 2011 Via E-mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England

Re: GlaxoSmithKline plc Form 20-F for Fiscal Year Ended December 31, 2010 Filed March 4, 2011 File No. 001-15170

Dear Mr. Dingemans: We have completed our review of your filing. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Joel Parker Joel Parker Accounting Branch Chief

Show Raw Text
November 30, 2011
 Via E-mail

Mr. Simon Dingemans
Chief Financial Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
England

Re: GlaxoSmithKline plc
  Form 20-F for Fiscal Year Ended December 31, 2010
  Filed March 4, 2011
  File No. 001-15170

Dear Mr. Dingemans:
 We have completed our review of your filing. We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States. We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
 Sincerely,  /s/ Joel Parker  Joel Parker  Accounting Branch Chief